Pfizer’s EAGLES trial finds Chantix safe in smokers with psychiatric disorders

Pfizer has reported positive results from EAGLES, a multi-centre, parallel-group, post-authorisation safety study / post-marketing requirement (PASS / PMR), which was conducted in 16 countries in collaboration with GlaxoSmithKline.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news

Related Links:

No abstract available
Source: Nursing - Category: Nursing Tags: Department: EDITORIAL Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Department: DRUG NEWS Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Department: ETHICS IN ACTION Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Department: ADVICE P.R.N Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Department: LEARNING CURVE Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Department: CLINICAL ROUNDS Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Feature: CE Connection Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Feature: CE Connection Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: CE Connection Source Type: research
No abstract available
Source: Nursing - Category: Nursing Tags: Feature Source Type: research
More News: Chantix | Marketing | Pfizer | Pharmaceuticals | Psychiatry | Smokers | Study